Compared to the most advanced targeted drugs (such as Erbitux, Keytruda, and Kymriah) that kill targeted cell populations or tissues (which cannot distinguish between pathogenic cell populations and normal cell populations), the new antigen products invented by BioMedicure have a significant advantage in immune killing of pathogenic cell populations and their derivatives or systems that carry various new antigens, without harming any normal cell populations/tissues/organs/systems (including the 12 major systems: skeletal, muscular, respiratory, digestive, endocrine, urinary, reproductive, circulatory, lymphatic, nervous, skin, and immune systems). When the new antigen products are used in non-drug therapies such as genomic therapy, customers will experience significant differences such as non-toxic side effects, multiple effects, long-term effects (no recurrence), the cumulative efficacy of new antigen products with different treatment courses, continuous upgrades of the immune system according to new antigens, and the restoration of the 12 major systems to normal. Because of these advantages, 10 cancer patients who used the customized new antigen products from BioMedicure 9 years ago have survived without disease for over 9 years, while their peers who did not customize and use the new antigen products have passed away one after another. Therefore, the value of new antigen products in cancer patients far exceeds the value of the most advanced targeted drugs currently available. The fundamental reason is that targeted drugs (such as Erbitux, Keytruda, and Kymriah) can only kill targeted cell populations (indiscriminately), and their efficacy and side effects vary from person to person. The obvious disadvantages of targeted drugs are single efficacy, short-term efficacy, inability to prevent recurrence, inability to prevent metastasis, and toxic side effects (such as damaging normal systems). In order to benefit more people, BioMedicure is willing to help eligible customers customize 100% targeted new antigen products for their causes at the price of the best targeted drugs.

 

The life systems of different people are not the same because they originate from different genomic programs of fertilized eggs from different parents (including more than 20,000 different gene sequences). However, each person's genomic program determines the morphology, structure, and various functions of their life system. The condition of the 12 major systems of the human body determines the health/sub-health/disease status of the body. Keeping the 12 major systems of the human body in a normal state at all times is a healthy state. The mutated cells, tumor cells, cancer cells, and their derivatives and sources of infection (including mycoplasma, viruses, bacteria, and fungi) form their own populations or systems, thereby affecting the normal functioning of the 12 major systems of the human body, manifesting as sub-health or disease states. Therefore, eliminating these mutated cells, tumor cells, cancer cells, and their derivatives and sources of infection (including mycoplasma, viruses, bacteria, and fungi) can restore the abnormal sub-health or disease state of the 12 major systems of the human body to a normal healthy state. The non-drug therapy or genomic therapy based on new antigen products cleverly utilizes the immune system's upgrading function to long-term immune kill various causes of sub-health and diseases, including mutated cells, tumor cells, cancer cells, and their derivatives and sources of infection (including mycoplasma, viruses, bacteria, and fungi), restoring the body to full health.

 

The BioMedicure team led by Dr. Qian Yong has strictly established a series of principles and goals for medical research. Among them, respecting and honoring the dignity of customers is the foremost company culture. Respecting and honoring the dignity of customers is not just about verbal care and attentive service; more importantly, it is about researching and respecting the genomic ecosystem of customers, including the immune system and the 12 major systems. In the process of serving and helping customers, BioMedicure will analyze with customers what may interfere with or damage the 12 major systems, including the immune system. Only when the 12 major systems are intact can the customized new antigen products achieve 100% immune killing of the populations or systems formed by mutated cells, tumor cells, cancer cells, and their derivatives and sources of infection (including mycoplasma, viruses, bacteria, and fungi), reflecting multiple long-term cumulative effects and achieving zero toxic side effects on the 12 major systems.